Covered recipient · General Payments record
JOHN L HINTON
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$22,119.20
- Reported across 367 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $458.89 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $139.51 | 12 |
| PFIZER INC. | $66.72 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $57.00 | 3 |
| ACADIA Pharmaceuticals Inc | $46.41 | 2 |
| CSL Behring | $38.44 | 1 |
| ARGENX US, INC. | $34.66 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.46 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $19.21 | 1 |
| Amgen Inc. | $18.34 | 1 |
| UCB, Inc. | $18.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.96 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921615 | CMS |
| ABBVIE INC. | $5.65 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921617 | CMS |
| ABBVIE INC. | $9.82 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921619 | CMS |
| ABBVIE INC. | $9.85 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921621 | CMS |
| ABBVIE INC. | $19.93 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921623 | CMS |
| ABBVIE INC. | $3.80 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921625 | CMS |
| ABBVIE INC. | $11.80 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921627 | CMS |
| ABBVIE INC. | $15.92 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921629 | CMS |
| ABBVIE INC. | $13.04 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921631 | CMS |
| ABBVIE INC. | $5.11 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921633 | CMS |
| ABBVIE INC. | $15.00 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921635 | CMS |
| ABBVIE INC. | $23.63 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921637 | CMS |
| ACADIA Pharmaceuticals Inc | $22.07 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147975341 | CMS |
| ACADIA Pharmaceuticals Inc | $24.34 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147975346 | CMS |
| Amgen Inc. | $18.34 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111599496 | CMS |
| ARGENX US, INC. | $34.66 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127221 | CMS |
| CSL Behring | $38.44 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134613079 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $19.21 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144507652 | CMS |
| Novartis Pharmaceuticals Corporation | $24.06 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086921477 | CMS |
| Novartis Pharmaceuticals Corporation | $18.99 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086921481 | CMS |
| Novartis Pharmaceuticals Corporation | $13.95 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086921493 | CMS |
| PFIZER INC. | $18.12 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131098806 | CMS |
| PFIZER INC. | $16.33 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131305579 | CMS |
| PFIZER INC. | $18.91 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131355582 | CMS |
| PFIZER INC. | $13.36 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131678083 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.46 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137576717 | CMS |
| UCB, Inc. | $18.14 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143260297 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.